We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
-14.85%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$637M
AUM Growth
-$214M
Cap. Flow
-$70.8M
Cap. Flow %
-11.11%
Top 10 Hldgs %
18.21%
Holding
581
New
183
Increased
73
Reduced
207
Closed
105

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$14.4M
2
NFLX icon
Netflix
NFLX
+$9.91M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$8M
4
TDOC icon
Teladoc Health
TDOC
+$7.16M
5
CIEN icon
Ciena
CIEN
+$6.16M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.1M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10M
3
BIIB icon
Biogen
BIIB
+$8.82M
4
BABA icon
Alibaba
BABA
+$8.42M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.33M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Healthcare 20.95%
3 Industrials 11.87%
4 Financials 8.28%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
451
Bank of New York Mellon
BNY
$110B
$4K ﹤0.01%
+84
New +$4.08K
MCD icon
452
McDonald's
MCD
$196B
$4K ﹤0.01%
+21
New +$3.72K
ENB icon
453
Enbridge
ENB
$112B
$3K ﹤0.01%
+85
New +$2.73K
F icon
454
Ford
F
$55.3B
$3K ﹤0.01%
+404
New +$3.6K
NTRS icon
455
Northern Trust
NTRS
$35.1B
$3K ﹤0.01%
+40
New +$3.75K
FRC
456
DELISTED
First Republic Bank
FRC
$3K ﹤0.01%
+35
New +$3.19K
MDR
457
DELISTED
McDermott International
MDR
$3K ﹤0.01%
+402
New +$4.25K
BR icon
458
Broadridge
BR
$19.5B
$2K ﹤0.01%
+18
New +$1.95K
CHX
459
DELISTED
ChampionX
CHX
$2K ﹤0.01%
+78
New +$2.87K
LUMN icon
460
Lumen
LUMN
$6.49B
$2K ﹤0.01%
+153
New +$2.92K
LYB icon
461
LyondellBasell Industries
LYB
$20.2B
$2K ﹤0.01%
+25
New +$2.29K
GMLP
462
DELISTED
Golar LNG Partners LP
GMLP
$2K ﹤0.01%
+184
New +$2.42K
MDA
463
DELISTED
MacDonald, Dettwiler and Assoc
MDA
$2K ﹤0.01%
+175
New +$2K
BDX icon
464
Becton Dickinson
BDX
$50.2B
$1K ﹤0.01%
+5
New +$1.16K
GF
465
New Germany Fund
GF
$188M
$1K ﹤0.01%
+99
New +$1.57K
PVH icon
466
PVH
PVH
$3.79B
$1K ﹤0.01%
+16
New +$1.83K
ABBV icon
467
AbbVie
ABBV
$450B
-6,359
Closed -$601K
ADAP
468
DELISTED
Adaptimmune Therapeutics
ADAP
-167,756
Closed -$2.27M
AGIO icon
469
Agios Pharmaceuticals
AGIO
$2.04B
-13,235
Closed -$1.02M
ALB icon
470
Albemarle
ALB
$15.6B
-29,630
Closed -$2.96M
ALNY icon
471
Alnylam Pharmaceuticals
ALNY
$30B
-13,365
Closed -$1.17M
ANET icon
472
Arista Networks
ANET
$262B
-17,456
Closed -$290K
ATNM icon
473
Actinium Pharmaceuticals
ATNM
$26.6M
-36,703
Closed -$816K
AUTL
474
Autolus Therapeutics
AUTL
$554M
-80,138
Closed -$2.46M
BA icon
475
Boeing
BA
$184B
-9,748
Closed -$3.63M

Similar funds

Essex Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Essex Investment Management held 581 positions worth $637M, down 25% from $851M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Essex Investment Management withdrew a net $70.8M in Q4 2018, closing 105 positions and reducing 207 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $5.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in NVIDIA worth $10.1M.

  • Essex Investment Management's largest Q4 2018 buy was NVIDIA: 3,018,520 shares worth $10.1M.
  • Essex Investment Management added most to VanEck Junior Gold Miners ETF in Q4 2018, an estimated $8M increase.
  • Essex Investment Management's biggest Q4 2018 reduction was Apple, cutting an estimated $10.1M.
  • Essex Investment Management fully exited Regeneron Pharmaceuticals in Q4 2018, selling an estimated $5.1M.
  • Essex Investment Management's ten largest holdings make up 18% of its $637M portfolio in Q4 2018.
  • Essex Investment Management opened 183 new positions and closed 105 in Q4 2018.
  • Essex Investment Management's portfolio value fell 25% quarter-over-quarter to $637M.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.